Immunoinformatics Study: Multi-Epitope Based Vaccine Design from SARS-CoV-2 Spike Glycoprotein
The coronavirus disease 2019 outbreak has become a huge challenge in the human sector for the past two years. The coronavirus is capable of mutating at a higher rate than other viruses. Thus, an approach for creating an effective vaccine is still needed to induce antibodies against multiple variants...
Saved in:
Published in | Vaccines (Basel) Vol. 11; no. 2; p. 399 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
01.02.2023
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The coronavirus disease 2019 outbreak has become a huge challenge in the human sector for the past two years. The coronavirus is capable of mutating at a higher rate than other viruses. Thus, an approach for creating an effective vaccine is still needed to induce antibodies against multiple variants with lower side effects. Currently, there is a lack of research on designing a multiepitope of the COVID-19 spike protein for the Indonesian population with comprehensive immunoinformatic analysis. Therefore, this study aimed to design a multiepitope-based vaccine for the Indonesian population using an immunoinformatic approach. This study was conducted using the SARS-CoV-2 spike glycoprotein sequences from Indonesia that were retrieved from the GISAID database. Three SARS-CoV-2 sequences, with IDs of EIJK-61453, UGM0002, and B.1.1.7 were selected. The CD8+ cytotoxic T-cell lymphocyte (CTL) epitope, CD4+ helper T lymphocyte (HTL) epitope, B-cell epitope, and IFN-γ production were predicted. After modeling the vaccines, molecular docking, molecular dynamics, in silico immune simulations, and plasmid vector design were performed. The designed vaccine is antigenic, non-allergenic, non-toxic, capable of inducing IFN-γ with a population reach of 86.29% in Indonesia, and has good stability during molecular dynamics and immune simulation. Hence, this vaccine model is recommended to be investigated for further study. |
---|---|
AbstractList | The coronavirus disease 2019 outbreak has become a huge challenge in the human sector for the past two years. The coronavirus is capable of mutating at a higher rate than other viruses. Thus, an approach for creating an effective vaccine is still needed to induce antibodies against multiple variants with lower side effects. Currently, there is a lack of research on designing a multiepitope of the COVID-19 spike protein for the Indonesian population with comprehensive immunoinformatic analysis. Therefore, this study aimed to design a multiepitope-based vaccine for the Indonesian population using an immunoinformatic approach. This study was conducted using the SARS-CoV-2 spike glycoprotein sequences from Indonesia that were retrieved from the GISAID database. Three SARS-CoV-2 sequences, with IDs of EIJK-61453, UGM0002, and B.1.1.7 were selected. The CD8+ cytotoxic T-cell lymphocyte (CTL) epitope, CD4+ helper T lymphocyte (HTL) epitope, B-cell epitope, and IFN-γ production were predicted. After modeling the vaccines, molecular docking, molecular dynamics, in silico immune simulations, and plasmid vector design were performed. The designed vaccine is antigenic, non-allergenic, non-toxic, capable of inducing IFN-γ with a population reach of 86.29% in Indonesia, and has good stability during molecular dynamics and immune simulation. Hence, this vaccine model is recommended to be investigated for further study. The coronavirus disease 2019 outbreak has become a huge challenge in the human sector for the past two years. The coronavirus is capable of mutating at a higher rate than other viruses. Thus, an approach for creating an effective vaccine is still needed to induce antibodies against multiple variants with lower side effects. Currently, there is a lack of research on designing a multiepitope of the COVID-19 spike protein for the Indonesian population with comprehensive immunoinformatic analysis. Therefore, this study aimed to design a multiepitope-based vaccine for the Indonesian population using an immunoinformatic approach. This study was conducted using the SARS-CoV-2 spike glycoprotein sequences from Indonesia that were retrieved from the GISAID database. Three SARS-CoV-2 sequences, with IDs of EIJK-61453, UGM0002, and B.1.1.7 were selected. The CD8+ cytotoxic T-cell lymphocyte (CTL) epitope, CD4+ helper T lymphocyte (HTL) epitope, B-cell epitope, and IFN-γ production were predicted. After modeling the vaccines, molecular docking, molecular dynamics, in silico immune simulations, and plasmid vector design were performed. The designed vaccine is antigenic, non-allergenic, non-toxic, capable of inducing IFN-γ with a population reach of 86.29% in Indonesia, and has good stability during molecular dynamics and immune simulation. Hence, this vaccine model is recommended to be investigated for further study.The coronavirus disease 2019 outbreak has become a huge challenge in the human sector for the past two years. The coronavirus is capable of mutating at a higher rate than other viruses. Thus, an approach for creating an effective vaccine is still needed to induce antibodies against multiple variants with lower side effects. Currently, there is a lack of research on designing a multiepitope of the COVID-19 spike protein for the Indonesian population with comprehensive immunoinformatic analysis. Therefore, this study aimed to design a multiepitope-based vaccine for the Indonesian population using an immunoinformatic approach. This study was conducted using the SARS-CoV-2 spike glycoprotein sequences from Indonesia that were retrieved from the GISAID database. Three SARS-CoV-2 sequences, with IDs of EIJK-61453, UGM0002, and B.1.1.7 were selected. The CD8+ cytotoxic T-cell lymphocyte (CTL) epitope, CD4+ helper T lymphocyte (HTL) epitope, B-cell epitope, and IFN-γ production were predicted. After modeling the vaccines, molecular docking, molecular dynamics, in silico immune simulations, and plasmid vector design were performed. The designed vaccine is antigenic, non-allergenic, non-toxic, capable of inducing IFN-γ with a population reach of 86.29% in Indonesia, and has good stability during molecular dynamics and immune simulation. Hence, this vaccine model is recommended to be investigated for further study. |
Audience | Academic |
Author | Ramadhan, Donny Anshori, Isa Syaifie, Putri Hawa Nugroho, Dwi Wahyu Harisna, Azza Hanif Umitaibatin, Ramadhita Shalannanda, Wervyan Arda, Adzani Gaisani Mardliyati, Etik Jauhar, Muhammad Miftah |
AuthorAffiliation | 1 Lab-on-Chip Group, Department of Biomedical Engineering, School of Electrical Engineering and Informatics, Bandung Institute of Technology, Bandung 40132, Indonesia 2 Nano Center Indonesia, Jl. Raya Puspiptek, South Tangerang 15314, Indonesia 5 Department of Telecommunication Engineering, School of Electrical Engineering and Informatics, Bandung Institute of Technology, Bandung 40132, Indonesia 4 Research Center for Vaccine and Drug, National Research and Innovation Agency (BRIN), Cibinong 16911, Indonesia 3 Research Center for Pharmaceutical Ingredients and Traditional Medicine, National Research and Innovation Agency (BRIN), Cibinong 16911, Indonesia |
AuthorAffiliation_xml | – name: 3 Research Center for Pharmaceutical Ingredients and Traditional Medicine, National Research and Innovation Agency (BRIN), Cibinong 16911, Indonesia – name: 4 Research Center for Vaccine and Drug, National Research and Innovation Agency (BRIN), Cibinong 16911, Indonesia – name: 2 Nano Center Indonesia, Jl. Raya Puspiptek, South Tangerang 15314, Indonesia – name: 5 Department of Telecommunication Engineering, School of Electrical Engineering and Informatics, Bandung Institute of Technology, Bandung 40132, Indonesia – name: 1 Lab-on-Chip Group, Department of Biomedical Engineering, School of Electrical Engineering and Informatics, Bandung Institute of Technology, Bandung 40132, Indonesia |
Author_xml | – sequence: 1 givenname: Ramadhita surname: Umitaibatin fullname: Umitaibatin, Ramadhita – sequence: 2 givenname: Azza Hanif surname: Harisna fullname: Harisna, Azza Hanif – sequence: 3 givenname: Muhammad Miftah orcidid: 0000-0002-5826-5904 surname: Jauhar fullname: Jauhar, Muhammad Miftah – sequence: 4 givenname: Putri Hawa orcidid: 0000-0001-8566-7960 surname: Syaifie fullname: Syaifie, Putri Hawa – sequence: 5 givenname: Adzani Gaisani orcidid: 0000-0002-2674-6295 surname: Arda fullname: Arda, Adzani Gaisani – sequence: 6 givenname: Dwi Wahyu orcidid: 0000-0002-7020-8582 surname: Nugroho fullname: Nugroho, Dwi Wahyu – sequence: 7 givenname: Donny orcidid: 0000-0001-6556-3160 surname: Ramadhan fullname: Ramadhan, Donny – sequence: 8 givenname: Etik surname: Mardliyati fullname: Mardliyati, Etik – sequence: 9 givenname: Wervyan orcidid: 0000-0002-4342-9718 surname: Shalannanda fullname: Shalannanda, Wervyan – sequence: 10 givenname: Isa orcidid: 0000-0001-5134-7264 surname: Anshori fullname: Anshori, Isa |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36851275$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ksFv0zAUxi00xLayOycUiQuXDMdOHJsDUiljVBpCojBxwnLt5-KSxMFOJvW_n0vHWCuwD7bs3_ue3_N3io463wFCzwp8TqnAr26U1q6DWBSYYCrEI3RCcM1yKui3owf7Y3QW4xqnIQrKWf0EHVPGq4LU1Qn6Pm_bsfOusz60anA6ZothNJvX2cexGVx-0bvB95C9VRFMdr1Lmb2D6FZdZoNvs8X08yKf-eucZIve_YTsstlo3wc_gOueosdWNRHO7tYJ-vr-4svsQ3716XI-m17luqrqIedKU024UoYIhcEqbQlVjOHaYqBLosoSmKW0UFQvhSiAC9BK1EbbJRMJmaD5Ttd4tZZ9cK0KG-mVk78PfFhJFVJ1DciKE2MwZdZoXmohlGHADOPWcFKWKe8Evdlp9eOyBaOhG4Jq9kT3bzr3Q678jRSClTx1fIJe3gkE_2uEOMjWRQ1NozrwY5Sk5ulvCOM0oS8O0LUfQ5dalahaMCaoqP5SK5UK2P5Vyqu3onJal7QSnLLtu8__QaVpoHU6ece6dL4X8PxhofcV_nFHAvAO0MHHGMDeIwWWWw_KQw-mEHYQot2QfOW3rXLN_wNvAW-d4lY |
CitedBy_id | crossref_primary_10_1016_j_humimm_2024_111117 crossref_primary_10_3390_vaccines12040358 crossref_primary_10_1007_s40203_024_00288_z crossref_primary_10_1016_j_jsps_2023_101917 crossref_primary_10_3389_fimmu_2024_1424307 crossref_primary_10_1016_j_heliyon_2024_e39142 crossref_primary_10_3390_biomedinformatics4020084 crossref_primary_10_1007_s12033_024_01303_6 crossref_primary_10_1007_s12033_024_01358_5 |
Cites_doi | 10.1016/j.celrep.2021.108890 10.1016/j.imu.2020.100500 10.1007/s00894-014-2278-5 10.1371/journal.pone.0073957 10.3389/fimmu.2021.693775 10.7554/eLife.07454 10.1093/molbev/msy096 10.1038/s41591-021-01347-0 10.1016/j.autrev.2020.102556 10.1186/1745-6150-3-38 10.1016/j.jmb.2015.09.014 10.1097/BOR.0000000000000776 10.1038/nature07830 10.2807/1560-7917.ES.2017.22.13.30494 10.1016/j.autrev.2020.102591 10.1186/1471-2105-8-4 10.1186/1471-2105-8-424 10.1016/S0006-3495(03)74736-5 10.3390/microorganisms9071542 10.1016/j.drudis.2020.03.006 10.1002/pro.3289 10.3390/vaccines9121459 10.7554/eLife.61312 10.1038/s41401-020-0485-4 10.3389/fimmu.2022.1035924 10.1016/S1359-6101(02)00044-8 10.1021/acs.jproteome.9b00874 10.1073/pnas.0603245103 10.3390/antib9030033 10.1016/j.dsx.2020.04.020 10.1016/j.cell.2020.02.058 10.3389/fimmu.2018.02061 10.1016/j.ijbiomac.2012.06.005 10.1016/S0022-2836(63)80023-6 10.1186/1471-2105-9-514 10.3906/biy-2006-1 10.1016/j.medntd.2020.100048 10.1002/prot.22927 10.1038/s41586-020-2012-7 10.1093/nar/gkn860 10.1038/s41541-022-00597-4 10.1093/nar/gkx346 10.1093/protein/10.9.999 10.1016/j.biotechadv.2011.09.013 10.1002/pro.5560020916 10.1016/j.imu.2021.100781 10.1016/j.imbio.2020.151955 10.1002/JLB.4MIR0420-619RR 10.1016/j.chom.2021.02.003 10.1016/j.bpj.2016.04.015 10.2807/1560-7917.ES.2020.25.23.2001005 10.1093/bioinformatics/btw514 10.1093/bib/bbaa416 10.1016/j.ijbiomac.2020.06.213 10.1136/jclinpath-2020-206658 10.1016/j.cell.2020.08.012 10.1002/jmv.25700 10.1038/msb.2011.75 10.3389/fimmu.2021.621706 10.1515/bmc.2010.022 10.3389/fimmu.2021.646972 10.1111/j.1600-065X.2008.00707.x 10.1093/bioinformatics/btv639 10.1124/dmd.104.000794 10.1016/j.febslet.2014.05.006 10.3389/fmicb.2014.00172 10.1371/journal.pcbi.1006457 10.1016/j.cell.2020.06.043 10.1111/j.1476-5381.2010.01127.x 10.1371/journal.pone.0009862 10.1073/pnas.1914677117 10.1038/s41579-021-00573-0 10.1021/ja026939x 10.4161/bbug.2.3.15367 10.1107/S0021889892009944 10.3390/vaccines8020288 10.1038/cmi.2017.92 10.7554/eLife.58603 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2023 MDPI AG 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2023 by the authors. 2023 |
Copyright_xml | – notice: COPYRIGHT 2023 MDPI AG – notice: 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2023 by the authors. 2023 |
DBID | AAYXX CITATION NPM 3V. 7T7 7XB 8FD 8FE 8FH 8FK 8G5 ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FR3 GNUQQ GUQSH HCIFZ LK8 M2O M7P MBDVC P64 PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI Q9U 7X8 5PM DOA |
DOI | 10.3390/vaccines11020399 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (purchase pre-March 2016) Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni Edition) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Engineering Research Database ProQuest Central Student Research Library Prep SciTech Premium Collection ProQuest Biological Science Collection Research Library Biological Science Database Research Library (Corporate) Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database Research Library Prep ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College Research Library (Alumni Edition) ProQuest Natural Science Collection Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Research Library Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition Biological Science Database ProQuest SciTech Collection Biotechnology and BioEngineering Abstracts ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database CrossRef PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 2076-393X |
ExternalDocumentID | oai_doaj_org_article_582dd036fdc84c99ad6e6d68fd8244f2 PMC9964839 A743598362 36851275 10_3390_vaccines11020399 |
Genre | Journal Article |
GeographicLocations | Indonesia |
GeographicLocations_xml | – name: Indonesia |
GrantInformation_xml | – fundername: Bandung Institute of Technology grantid: ITB – fundername: Bandung Institute of Technology (ITB) |
GroupedDBID | 53G 5VS 8FE 8FH 8G5 AADQD AAHBH AAYXX ABUWG ADBBV AEUYN AFKRA AFZYC ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BBNVY BCNDV BENPR BHPHI BPHCQ CCPQU CITATION DIK DWQXO GNUQQ GROUPED_DOAJ GUQSH HCIFZ HYE IAO IHR ITC KQ8 LK8 M2O M48 M7P MODMG M~E OK1 PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RNS RPM NPM PQGLB PMFND 3V. 7T7 7XB 8FD 8FK C1K FR3 MBDVC P64 PKEHL PQEST PQUKI Q9U 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c557t-8ac3c28aad29a0efacf23a6607f0e3b2a44e6f331a3cb991e89eca97dcfb690e3 |
IEDL.DBID | BENPR |
ISSN | 2076-393X |
IngestDate | Wed Aug 27 01:31:39 EDT 2025 Thu Aug 21 18:37:56 EDT 2025 Fri Jul 11 01:10:13 EDT 2025 Sun Jul 13 05:22:04 EDT 2025 Tue Jun 17 22:13:45 EDT 2025 Tue Jun 10 21:15:14 EDT 2025 Mon Jul 21 05:44:24 EDT 2025 Tue Jul 01 01:10:58 EDT 2025 Thu Apr 24 23:06:47 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | epitope prediction antigenic epitope TLR-3 spike glycoprotein LR-4 |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c557t-8ac3c28aad29a0efacf23a6607f0e3b2a44e6f331a3cb991e89eca97dcfb690e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-4342-9718 0000-0001-6556-3160 0000-0002-2674-6295 0000-0001-5134-7264 0000-0002-5826-5904 0000-0001-8566-7960 0000-0002-7020-8582 |
OpenAccessLink | https://www.proquest.com/docview/2779669395?pq-origsite=%requestingapplication% |
PMID | 36851275 |
PQID | 2779669395 |
PQPubID | 2032320 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_582dd036fdc84c99ad6e6d68fd8244f2 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9964839 proquest_miscellaneous_2780762683 proquest_journals_2779669395 gale_infotracmisc_A743598362 gale_infotracacademiconefile_A743598362 pubmed_primary_36851275 crossref_primary_10_3390_vaccines11020399 crossref_citationtrail_10_3390_vaccines11020399 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-02-01 |
PublicationDateYYYYMMDD | 2023-02-01 |
PublicationDate_xml | – month: 02 year: 2023 text: 2023-02-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | Vaccines (Basel) |
PublicationTitleAlternate | Vaccines (Basel) |
PublicationYear | 2023 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Chen (ref_82) 2012; 30 McCabe (ref_25) 2019; 48 Zhao (ref_12) 2022; 7 Laskowski (ref_51) 2017; 27 Mezouar (ref_81) 2020; 108 Bravo (ref_84) 2008; 3 Ahammad (ref_36) 2020; 162 Yang (ref_38) 2020; 117 ref_52 Su (ref_41) 1963; 7 Parvizpour (ref_14) 2020; 25 Sahoo (ref_46) 2012; 51 Dominguez (ref_43) 2003; 125 Greaney (ref_62) 2021; 29 ref_60 Pillay (ref_3) 2020; 73 Xu (ref_78) 1997; 10 Angileri (ref_68) 2020; 19 Laskowski (ref_40) 1993; 26 Kumar (ref_19) 2018; 35 Bowick (ref_9) 2011; 2 Park (ref_47) 2009; 458 Chesler (ref_64) 2002; 13 ref_23 Andreano (ref_63) 2021; 27 Donald (ref_74) 2010; 79 Xue (ref_48) 2016; 32 Muir (ref_57) 2021; 34 Li (ref_7) 2020; 8 Sarkar (ref_37) 2020; 225 Korber (ref_59) 2020; 182 ref_29 Starr (ref_58) 2020; 182 Harvey (ref_56) 2021; 19 Sanches (ref_71) 2021; 12 Williams (ref_28) 2004; 32 Castiglione (ref_53) 2021; 12 Sievers (ref_20) 2011; 7 Walls (ref_5) 2020; 181 Hu (ref_80) 2008; 226 Ahsan (ref_8) 2021; 22 Gustiananda (ref_16) 2021; 9 ref_72 Reynisson (ref_30) 2020; 19 ref_70 Shu (ref_18) 2017; 22 Anand (ref_67) 2020; 9 Huang (ref_6) 2020; 41 Febrianti (ref_17) 2022; 17 ref_35 Rodrigues (ref_44) 2016; 428 ref_33 Meuzelaar (ref_76) 2016; 110 ref_32 Laskowski (ref_50) 2009; 37 Vangone (ref_49) 2015; 4 ref_73 Dimitrov (ref_34) 2014; 20 Liu (ref_66) 2020; 33 Ceraolo (ref_1) 2020; 92 Acar (ref_10) 2020; 44 Hollingsworth (ref_39) 2010; 1 Yousaf (ref_13) 2022; 13 Andreatta (ref_24) 2015; 32 Saitou (ref_22) 1987; 4 White (ref_27) 2001; 29 Zhang (ref_15) 2017; 15 Ghosh (ref_75) 2003; 85 Astuti (ref_4) 2020; 14 Weisblum (ref_61) 2020; 9 Hughes (ref_26) 2011; 162 Colovos (ref_42) 1993; 2 Pace (ref_77) 2014; 588 Hossain (ref_54) 2020; 22 Lee (ref_65) 2018; 9 Jebin (ref_79) 2021; 27 Rosano (ref_83) 2014; 5 Zhou (ref_2) 2020; 579 Jespersen (ref_31) 2017; 45 Ding (ref_55) 2021; 12 Oreshkova (ref_11) 2020; 25 Jones (ref_21) 1992; 8 Bell (ref_45) 2006; 103 Lucchese (ref_69) 2020; 19 |
References_xml | – volume: 34 start-page: 108890 year: 2021 ident: ref_57 article-title: The Effect of Spike Mutations on SARS-CoV-2 Neutralization publication-title: Cell Rep. doi: 10.1016/j.celrep.2021.108890 – volume: 22 start-page: 100500 year: 2020 ident: ref_54 article-title: Immunoinformatics approach to designing a multi-epitope vaccine against Saint Louis Encephalitis Virus publication-title: Informatics Med. Unlocked doi: 10.1016/j.imu.2020.100500 – volume: 20 start-page: 2278 year: 2014 ident: ref_34 article-title: AllerTOP v. 2—A Server for in Silico Prediction of Allergens publication-title: J. Mol. Model doi: 10.1007/s00894-014-2278-5 – ident: ref_35 doi: 10.1371/journal.pone.0073957 – volume: 12 start-page: 3231 year: 2021 ident: ref_55 article-title: Crucial Mutations of Spike Protein on SARS-CoV-2 Evolved to Variant Strains Escaping Neutralization of Convalescent Plasmas and RBD-Specific Monoclonal Antibodies publication-title: Front. Immunol. doi: 10.3389/fimmu.2021.693775 – volume: 29 start-page: 957 year: 2001 ident: ref_27 article-title: Pharmacokinetic theory of cassette dosing in drug discovery screening publication-title: Drug Metab. Dispos. – volume: 4 start-page: e07454 year: 2015 ident: ref_49 article-title: Contacts-based prediction of binding affinity in protein–protein complexes publication-title: Elife doi: 10.7554/eLife.07454 – volume: 35 start-page: 1547 year: 2018 ident: ref_19 article-title: MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms publication-title: Mol. Biol. Evol. doi: 10.1093/molbev/msy096 – volume: 27 start-page: 759 year: 2021 ident: ref_63 article-title: SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies publication-title: Nat. Med. doi: 10.1038/s41591-021-01347-0 – volume: 19 start-page: 102556 year: 2020 ident: ref_69 article-title: Molecular Mimicry between SARS-CoV-2 and Respiratory Pacemaker Neurons publication-title: Autoimmun. Rev. doi: 10.1016/j.autrev.2020.102556 – volume: 3 start-page: 38 year: 2008 ident: ref_84 article-title: CAIcal: A combined set of tools to assess codon usage adaptation publication-title: Biol. Direct doi: 10.1186/1745-6150-3-38 – volume: 428 start-page: 720 year: 2016 ident: ref_44 article-title: The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2015.09.014 – volume: 33 start-page: 155 year: 2020 ident: ref_66 article-title: COVID-19 and autoimmune diseases publication-title: Curr. Opin. Rheumatol. doi: 10.1097/BOR.0000000000000776 – volume: 458 start-page: 1191 year: 2009 ident: ref_47 article-title: The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex publication-title: Nature doi: 10.1038/nature07830 – volume: 22 start-page: 30494 year: 2017 ident: ref_18 article-title: GISAID: Global Initiative on Sharing All Influenza Data–from Vision to Reality publication-title: Eurosurveillance doi: 10.2807/1560-7917.ES.2017.22.13.30494 – volume: 19 start-page: 102591 year: 2020 ident: ref_68 article-title: Molecular mimicry may explain multi-organ damage in COVID-19 publication-title: Autoimmun. Rev. doi: 10.1016/j.autrev.2020.102591 – ident: ref_33 doi: 10.1186/1471-2105-8-4 – ident: ref_23 doi: 10.1186/1471-2105-8-424 – volume: 85 start-page: 3187 year: 2003 ident: ref_75 article-title: Role of Backbone Hydration and Salt-Bridge Formation in Stability of α-Helix in Solution publication-title: Biophys. J. doi: 10.1016/S0006-3495(03)74736-5 – volume: 48 start-page: D783 year: 2019 ident: ref_25 article-title: Allele frequency net database (AFND) 2020 update: Gold-standard data classification, open access genotype data and new query tools publication-title: Nucleic Acids Res. – ident: ref_60 doi: 10.3390/microorganisms9071542 – volume: 25 start-page: 1034 year: 2020 ident: ref_14 article-title: Epitope-based vaccine design: A comprehensive overview of bioinformatics approaches publication-title: Drug Discov. Today doi: 10.1016/j.drudis.2020.03.006 – volume: 27 start-page: 129 year: 2017 ident: ref_51 article-title: PDBsum: Structural summaries of PDB entries publication-title: Protein Sci. doi: 10.1002/pro.3289 – volume: 9 start-page: 1459 year: 2021 ident: ref_16 article-title: Immunoinformatics Analysis of SARS-CoV-2 ORF1ab Polyproteins to Identify Promiscuous and Highly Conserved T-Cell Epitopes to Formulate Vaccine for Indonesia and the World Population publication-title: Vaccines doi: 10.3390/vaccines9121459 – volume: 9 start-page: e61312 year: 2020 ident: ref_61 article-title: Escape from Neutralizing Antibodies by SARS-CoV-2 Spike Protein Variants publication-title: Elife doi: 10.7554/eLife.61312 – volume: 41 start-page: 1141 year: 2020 ident: ref_6 article-title: Structural and Functional Properties of SARS-CoV-2 Spike Protein: Potential Antivirus Drug Development for COVID-19 publication-title: Acta Pharm. Sin. doi: 10.1038/s41401-020-0485-4 – volume: 13 start-page: 1035924 year: 2022 ident: ref_13 article-title: Immuno-informatics profiling of monkeypox virus cell surface binding protein for designing a next generation multi-valent peptide-based vaccine publication-title: Front. Immunol. doi: 10.3389/fimmu.2022.1035924 – volume: 13 start-page: 441 year: 2002 ident: ref_64 article-title: The role of IFN-γ in immune responses to viral infections of the central nervous system publication-title: Cytokine Growth Factor Rev. doi: 10.1016/S1359-6101(02)00044-8 – volume: 19 start-page: 2304 year: 2020 ident: ref_30 article-title: Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data publication-title: J. Proteome Res. doi: 10.1021/acs.jproteome.9b00874 – volume: 103 start-page: 8792 year: 2006 ident: ref_45 article-title: The dsRNA binding site of human Toll-like receptor 3 publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.0603245103 – ident: ref_70 doi: 10.3390/antib9030033 – volume: 14 start-page: 407 year: 2020 ident: ref_4 article-title: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An Overview of Viral Structure and Host Response publication-title: Diabetes Metab. Syndr. Clin. Res. Rev. doi: 10.1016/j.dsx.2020.04.020 – volume: 181 start-page: 281 year: 2020 ident: ref_5 article-title: Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein publication-title: Cell doi: 10.1016/j.cell.2020.02.058 – volume: 9 start-page: 2061 year: 2018 ident: ref_65 article-title: The Dual Nature of Type I and Type II Interferons publication-title: Front. Immunol. doi: 10.3389/fimmu.2018.02061 – volume: 51 start-page: 531 year: 2012 ident: ref_46 article-title: Structural insights of rohu TLR3, its binding site analysis with fish reovirus dsRNA, poly I:C and zebrafish TRIF publication-title: Int. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2012.06.005 – volume: 7 start-page: 95 year: 1963 ident: ref_41 article-title: Stereochemistry of Polypeptide Chain Configurations publication-title: J. Mol. Biol. doi: 10.1016/S0022-2836(63)80023-6 – ident: ref_32 doi: 10.1186/1471-2105-9-514 – volume: 44 start-page: 215 year: 2020 ident: ref_10 article-title: An insight into the epitope-based peptide vaccine design strategy and studies against COVID-19 publication-title: Turk. J. Biol. doi: 10.3906/biy-2006-1 – volume: 8 start-page: 100048 year: 2020 ident: ref_7 article-title: Spike Protein-Based Epitopes Predicted against SARS-CoV-2 through Literature Mining publication-title: Med. Nov. Technol. Devices doi: 10.1016/j.medntd.2020.100048 – ident: ref_72 – volume: 79 start-page: 898 year: 2010 ident: ref_74 article-title: Salt bridges: Geometrically specific, designable interactions publication-title: Proteins Struct. Funct. Bioinform. doi: 10.1002/prot.22927 – volume: 579 start-page: 270 year: 2020 ident: ref_2 article-title: A pneumonia outbreak associated with a new coronavirus of probable bat origin publication-title: Nature doi: 10.1038/s41586-020-2012-7 – volume: 37 start-page: D355 year: 2009 ident: ref_50 article-title: PDBsum New Things publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkn860 – volume: 7 start-page: 167 year: 2022 ident: ref_12 article-title: Challenges and Developments in Universal Vaccine Design against SARS-CoV-2 Variants publication-title: NPJ Vaccines doi: 10.1038/s41541-022-00597-4 – volume: 45 start-page: W24 year: 2017 ident: ref_31 article-title: BepiPred-2.0: Improving sequence-based B-cell epitope prediction using conformational epitopes publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkx346 – volume: 10 start-page: 999 year: 1997 ident: ref_78 article-title: Hydrogen bonds and salt bridges across protein-protein interfaces publication-title: Protein Eng. Des. Sel. doi: 10.1093/protein/10.9.999 – volume: 30 start-page: 1102 year: 2012 ident: ref_82 article-title: Bacterial expression systems for recombinant protein production: E. coli and beyond publication-title: Biotechnol. Adv. doi: 10.1016/j.biotechadv.2011.09.013 – volume: 2 start-page: 1511 year: 1993 ident: ref_42 article-title: Verification of protein structures: Patterns of nonbonded atomic interactions publication-title: Protein Sci. doi: 10.1002/pro.5560020916 – volume: 27 start-page: 100781 year: 2021 ident: ref_79 article-title: Development of an in silico multi-epitope vaccine against SARS-CoV-2 by précised immune-informatics approaches publication-title: Inform. Med. Unlocked doi: 10.1016/j.imu.2021.100781 – volume: 225 start-page: 151955 year: 2020 ident: ref_37 article-title: Immunoinformatics-Guided Designing of Epitope-Based Subunit Vaccines against the SARS Coronavirus-2 (SARS-CoV-2) publication-title: Immunobiology doi: 10.1016/j.imbio.2020.151955 – volume: 108 start-page: 419 year: 2020 ident: ref_81 article-title: Changing the paradigm of IFN-γ at the interface between innate and adaptive immunity: Macrophage-derived IFN-γ publication-title: J. Leukoc. Biol. doi: 10.1002/JLB.4MIR0420-619RR – volume: 29 start-page: 463 year: 2021 ident: ref_62 article-title: Comprehensive Mapping of Mutations in the SARS-CoV-2 Receptor-Binding Domain That Affect Recognition by Polyclonal Human Plasma Antibodies publication-title: Cell Host Microbe doi: 10.1016/j.chom.2021.02.003 – volume: 110 start-page: 2328 year: 2016 ident: ref_76 article-title: Influence of Glu/Arg, Asp/Arg, and Glu/Lys Salt Bridges on α-Helical Stability and Folding Kinetics publication-title: Biophys. J. doi: 10.1016/j.bpj.2016.04.015 – volume: 25 start-page: 2001005 year: 2020 ident: ref_11 article-title: SARS-CoV-2 Infection in Farmed Minks, The Netherlands, April and May 2020 publication-title: Eurosurveillance doi: 10.2807/1560-7917.ES.2020.25.23.2001005 – volume: 8 start-page: 275 year: 1992 ident: ref_21 article-title: The rapid generation of mutation data matrices from protein sequences publication-title: Comput. Appl. Biosci. – volume: 32 start-page: 3676 year: 2016 ident: ref_48 article-title: PRODIGY: A web server for predicting the binding affinity of protein–protein complexes publication-title: Bioinformatics doi: 10.1093/bioinformatics/btw514 – volume: 22 start-page: 714 year: 2021 ident: ref_8 article-title: Bioinformatics Resources Facilitate Understanding and Harnessing Clinical Research of SARS-CoV-2 publication-title: Brief Bioinform. doi: 10.1093/bib/bbaa416 – volume: 162 start-page: 820 year: 2020 ident: ref_36 article-title: Designing a Novel MRNA Vaccine against SARS-CoV-2: An Immunoinformatics Approach publication-title: Int. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2020.06.213 – volume: 73 start-page: 366 year: 2020 ident: ref_3 article-title: Gene of the Month: The 2019-NCoV/SARS-CoV-2 Novel Coronavirus Spike Protein publication-title: J. Clin. Pathol. doi: 10.1136/jclinpath-2020-206658 – volume: 182 start-page: 1295 year: 2020 ident: ref_58 article-title: Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding publication-title: Cell doi: 10.1016/j.cell.2020.08.012 – volume: 92 start-page: 522 year: 2020 ident: ref_1 article-title: Genomic variance of the 2019-nCoV coronavirus publication-title: J. Med. Virol. doi: 10.1002/jmv.25700 – volume: 7 start-page: 539 year: 2011 ident: ref_20 article-title: Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega publication-title: Mol. Syst. Biol. doi: 10.1038/msb.2011.75 – volume: 12 start-page: 621706 year: 2021 ident: ref_71 article-title: Immunoinformatics Design of Multi-Epitope Peptide-Based Vaccine Against Schistosoma mansoni Using Transmembrane Proteins as a Target publication-title: Front. Immunol. doi: 10.3389/fimmu.2021.621706 – volume: 1 start-page: 271 year: 2010 ident: ref_39 article-title: A fresh look at the Ramachandran plot and the occurrence of standard structures in proteins publication-title: Biomol. Concepts doi: 10.1515/bmc.2010.022 – volume: 12 start-page: 3433 year: 2021 ident: ref_53 article-title: From Infection to Immunity: Understanding the Response to SARS-CoV2 through in-Silico Modeling publication-title: Front. Immunol. doi: 10.3389/fimmu.2021.646972 – volume: 226 start-page: 41 year: 2008 ident: ref_80 article-title: Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2008.00707.x – volume: 32 start-page: 511 year: 2015 ident: ref_24 article-title: Gapped sequence alignment using artificial neural networks: Application to the MHC class I system publication-title: Bioinformatics doi: 10.1093/bioinformatics/btv639 – volume: 32 start-page: 1201 year: 2004 ident: ref_28 article-title: Drug-drug interactions for udp-glucuronosyltransferase substrates: A pharmacokinetic explanation for typically observed low exposure (auci/auc) ratios publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.104.000794 – volume: 588 start-page: 2177 year: 2014 ident: ref_77 article-title: Forces stabilizing proteins publication-title: FEBS Lett. doi: 10.1016/j.febslet.2014.05.006 – volume: 17 start-page: 467 year: 2022 ident: ref_17 article-title: In-Silico Analysis of Recombinant Protein Vaccines Based on the Spike Protein of Indonesian SARS-CoV-2 through a Reverse Vaccinology Approach publication-title: J. Taibah Univ. Med. Sci. – volume: 5 start-page: 172 year: 2014 ident: ref_83 article-title: Recombinant protein expression in Escherichia coli: Advances and challenges publication-title: Front. Microbiol. doi: 10.3389/fmicb.2014.00172 – ident: ref_29 doi: 10.1371/journal.pcbi.1006457 – volume: 182 start-page: 812 year: 2020 ident: ref_59 article-title: Tracking Changes in SARS-CoV-2 Spike: Evidence That D614G Increases Infectivity of the COVID-19 Virus publication-title: Cell doi: 10.1016/j.cell.2020.06.043 – volume: 162 start-page: 1239 year: 2011 ident: ref_26 article-title: Principles of early drug discovery publication-title: Br. J. Pharmacol. doi: 10.1111/j.1476-5381.2010.01127.x – ident: ref_52 doi: 10.1371/journal.pone.0009862 – volume: 4 start-page: 406 year: 1987 ident: ref_22 article-title: The neighbor-joining method: A new method for reconstructing phylogenetic trees publication-title: Mol. Biol. Evol. – volume: 117 start-page: 1496 year: 2020 ident: ref_38 article-title: Improved protein structure prediction using predicted interresidue orientations publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1914677117 – volume: 19 start-page: 409 year: 2021 ident: ref_56 article-title: SARS-CoV-2 Variants, Spike Mutations and Immune Escape publication-title: Nat. Rev. Microbiol. doi: 10.1038/s41579-021-00573-0 – volume: 125 start-page: 1731 year: 2003 ident: ref_43 article-title: HADDOCK: A Protein−Protein Docking Approach Based on Biochemical or Biophysical Information publication-title: J. Am. Chem. Soc. doi: 10.1021/ja026939x – volume: 2 start-page: 129 year: 2011 ident: ref_9 article-title: Vaccine and Adjuvant Design for Emerging Viruses: Mutations, Deletions, Segments and Signaling publication-title: Bioeng. Bugs doi: 10.4161/bbug.2.3.15367 – volume: 26 start-page: 283 year: 1993 ident: ref_40 article-title: PROCHECK: A program to check the stereochemical quality of protein structures publication-title: J. Appl. Crystallogr. doi: 10.1107/S0021889892009944 – ident: ref_73 doi: 10.3390/vaccines8020288 – volume: 15 start-page: 182 year: 2017 ident: ref_15 article-title: Multi-epitope vaccines: A promising strategy against tumors and viral infections publication-title: Cell. Mol. Immunol. doi: 10.1038/cmi.2017.92 – volume: 9 start-page: e58603 year: 2020 ident: ref_67 article-title: SARS-CoV-2 Strategically Mimics Proteolytic Activation of Human ENaC publication-title: Elife doi: 10.7554/eLife.58603 |
SSID | ssj0000913867 |
Score | 2.2688856 |
Snippet | The coronavirus disease 2019 outbreak has become a huge challenge in the human sector for the past two years. The coronavirus is capable of mutating at a... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 399 |
SubjectTerms | Amino acids Antibodies Antigenic determinants antigenic epitope Antigens Binding sites CD4 antigen CD8 antigen Coronaviruses COVID-19 COVID-19 vaccines Cytotoxicity Design Dynamic stability epitope prediction Epitopes Glycoproteins Health aspects LR-4 Lymphocytes Lymphocytes B Lymphocytes T Molecular docking Molecular dynamics Mutation Phylogenetics Population Proteins Severe acute respiratory syndrome coronavirus 2 Side effects Simulation Spike glycoprotein Spike protein TLR-3 Vaccines Vectors (Biology) Viral diseases Viral infections γ-Interferon |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELfQnnhBfBMYyEhoCGlWXTvxB2_d2BhIoIlu056I_CkqpqSiHVL_e85O1jYgwQsPeakvUew73--uufsZoVeecltZE4jTkRNweJRYcAlkbK3gpoox5j_cPn0WJ-flx8vqcuuor1QT1tEDdws3qhTz8EARvVOl09p4EYQXKnoFyBSz9wXM20qmsg_WY66E7L5LcsjrRz-NS1-qFwB3jPJM9brBoUzX_6dT3kKlYcXkFgQd30V3-tgRT7p3voduheY-2jvtyKdX-_hs00u12Md7-HRDS716gL5-SK0gbc-UmmRwKiJcvcW5CZcczWFzzwM-AFzz-KKbCH6XKzxw6kLB08mXKTlsLwjD0_nse8Dvr1auzUwPs-YhOj8-Ojs8If3pCsRVlVwSZRx3TBnjmTY0ROMi40YIKiMN3DJTlkFEzseGOwtRZFA6OKOld9FCSh34I7TTtE14gjCrQK2cUWG0LmXg2nlJSyfgitwJW6DRzVrXrqceTydgXNWQgiTt1L9rp0Bv1nfMO9qNv8geJPWt5RJhdv4BzKjuzaj-lxkV6HVSfp2UAK_mTN-dABNMBFn1BCKtSiuA-wLtDiRhO7rh8I351L07WNRMSkgrNddVgV6uh9OdqcStCe11klEUkEkoXqDHnbWtp5ROCUhM_AWSAzsczHk40sy-ZbJwyGdLCIKf_o9FeoZuM4jxuqL1XbSz_HEdnkNMtrQv8vb7BXaGOFY priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgvPCC-CYwkJHQENLMUjvxBxJC3dgYSEMTXac9LfInVFRJaTtE_3vOSdouMO0hL_FZinN3vt8ldz8j9MqlzORGe2JVYAQ2vJQY2BJIzxjOdB5CqD-4HX3lh8Psy1l-tm6Pbl_g7MrULp4nNZyO3_75tfgADv8-ZpyQsu_81jb-hJ5BJKMpBNyb6BbEJRHd9KgF-_W-rHpMctH8q7xyYic21RT-_2_UlyJVt4ryUlg6uIvutHgS9xsDuIdu-PI-2jpuCKkX2_hk3V8128Zb-HhNVb14gM4_x_aQqmVPjTI4FhYu3uG6MZfsT8DhJx7vQqxz-LRZCP5YV33g2JmCB_1vA7JXnRKKB5PRT48_jRe2qtkfRuVDNDzYP9k7JO2JC8TmuZgTqS2zVGrtqNKpD9oGyjTnqQipZ4bqLPM8MNbTzBpAll4qb7USzgYDabZnj9BGWZX-CcI0B1UzmnKtVCY8U9aJNLMcrsAsNwnaWb7rwrZ05PFUjHEBaUnUTvGvdhL0ZjVj0lBxXCO7G9W3kosk2vWNavq9aH2yyCV1YKs8OCszq5R23HPHZXASQE-gCXodlV9EJcCjWd12LMACI2lW0Qf0lSsJECBBmx1JcFHbHV6aT7G08IIKAammYipP0MvVcJwZy95KX11EGZlCtOKSJehxY22rJcWTAyI7f4JExw47a-6OlKMfNYE45LgZAOOn1z_WM3SbAqJrStQ30cZ8euGfAwKbmxe1Y_0FeJcziA priority: 102 providerName: Scholars Portal |
Title | Immunoinformatics Study: Multi-Epitope Based Vaccine Design from SARS-CoV-2 Spike Glycoprotein |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36851275 https://www.proquest.com/docview/2779669395 https://www.proquest.com/docview/2780762683 https://pubmed.ncbi.nlm.nih.gov/PMC9964839 https://doaj.org/article/582dd036fdc84c99ad6e6d68fd8244f2 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdge-EF8U1gTJ6EhpBmNbMTx-YFtVvHQNpUrdu0JyLHH1AxJWHtkPrfc07cdAFpD-1DfZHi3vm-fPc7hN6bmBVpoSzR0jECCi8mBagEsl8UnKnUOdck3E5O-fFF8u0qvQoJt3koq1zpxEZRm0r7HPmAZhl45pLJ9HP9m_ipUf52NYzQeIg2QQULCL42R-PTyVmXZfGol4Jn7f0kg_h-8Edpf2M9B7NHY9ZAvq7tUQPb_79yvmOd-pWTd0zR0RP0OPiQeNgy_Sl6YMtnaHfSglAv9_D5uqdqvod38WQNT718jr5_9S0hVUBM9TTYFxMuP-GmGZeMazjktcUjsG8GX7YbwYdNpQf23Sh4OjybkoPqklA8rWe_LP5yvdRVg_gwK1-gi6Px-cExCVMWiE7TbEGE0kxToZShUsXWKe0oU5zHmYstK6hKEssdY_uK6QK8SSuk1UpmRrsCQmvLXqKNsirta4RpCuxlNOZKyiSzTGqTxYnm8HFM8yJCg9V_nesAQe4nYVznEIp47uT_cidCH7sn6hZ-4x7akWdfR-eBs5sfqpsfeTiHeSqoAfnkzmiRaCmV4ZYbLpwR4Og4GqEPnvm5ZwK8mlahSwE26IGy8iF4XKkUYPYjtNWjhGOp-8sr8cmDWpjnayGO0E637J_0pW6lrW49jYjBQnHBIvSqlbZuS35agEfkj1DWk8Penvsr5exnAxoOcW0CzvCb-1_rLXpEwYtry9K30Mbi5ta-A69rUWyHo7XdZC3g-yQRfwEZqDKM |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-N7gFeEN8LDDASDCEtamYnToyEULt1tGyrqrWb9kRwHBsqpqSsHaj_FH8j5yRtF5D2toe8xJcozp3vw777HcDr1GNJkEjtKmGYiwrPcxNUCe5OknAmA2NMseF21OfdE__zWXC2Bn8WtTA2rXKhEwtFnebK7pE3aRiiZy6YCD5Ofrq2a5Q9XV200CjF4kDPf2PINv3Q20P-vqF0vzPa7bpVVwFXBUE4cyOpmKKRlCkV0tNGKkOZ5NwLjadZQqXva24Y25FMJeg96UhoJUWYKpNgKKkZvvcWrPsMQ5kGrLc7_cHxclfHomxGPCzPQxkTXvOXVPaEfIpmlnqsgJhd2b-iTcD_xuCKNaxnal4xffv34G7ls5JWKWT3YU1nD2BrUIJez7fJaFXDNd0mW2SwgsOeP4QvPVuCklcIrZaG2OTF-XtSFP-6nQkqlYkmbbSnKTktJ0L2iswSYqtfyLB1PHR381OXkuFk_EOTT-dzlRcIE-PsEZzcyP9_DI0sz_QGEBqgODHqcSmEH2omVBp6vuJ4GaZ44kBz8a9jVUGe284b5zGGPpY78b_cceDd8olJCfdxDW3bsm9JZ4G6ixv5xbe4WvdxENEU1wM3qYp8JYRMueYpj0waoWNlqANvLfNjywT8NCWrqgicoAXmilvo4QUiQjfDgc0aJaoBVR9eiE9cqaFpvFo0DrxaDtsnbWpdpvNLSxN5aBF5xBx4Ukrbckq2O4HtAOBAWJPD2pzrI9n4ewFSjnG0j8730-s_6yXc7o6ODuPDXv_gGdyh6EGWKfGb0JhdXOrn6PHNkhfVMiPw9aZX9l-tnm_6 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTkK8IBgfCwxmJBhCWtTMTpwYCaF2bVkZVNW6TXsiOI4NFVNS1g7Uf42_jnOStgtIe9tDXuJLFOfO92Hf_Q7gZeqxJEikdpUwzEWF57kJqgR3L0k4k4Expthw-zzgByf-x7PgbA3-LGphbFrlQicWijrNld0jb9IwRM9cMBE0TZUWMez03k9-uraDlD1pXbTTKEXkUM9_Y_g2fdfvIK9fUdrrHu8fuFWHAVcFQThzI6mYopGUKRXS00YqQ5nk3AuNp1lCpe9rbhjbk0wl6EnpSGglRZgqk2BYqRm-9xashxgVeQ1Yb3cHw6PlDo9F3Ix4WJ6NMia85i-p7Gn5FE0u9VgBN7uyhUXLgP8NwxXLWM_avGIGe_fgbuW_klYpcPdhTWcbsDMsAbDnu-R4Vc813SU7ZLiCxp4_gC99W46SV2itlobYRMb5W1IUArvdCSqYiSZttK0pOS0nQjpFlgmxlTBk1Doaufv5qUvJaDL-ocmH87nKC7SJcfYQTm7k_z-CRpZnehMIDVC0GPW4FMIPNRMqDT1fcbwMUzxxoLn417Gq4M9tF47zGMMgy534X-448Gb5xKSE_riGtm3Zt6SzoN3FjfziW1zpgDiIaIprg5tURb4SQqZc85RHJo3QyTLUgdeW-bFlAn6aklWFBE7QgnTFLfT2AhGhy-HAVo0SVYKqDy_EJ65U0jReLSAHXiyH7ZM2zS7T-aWliTy0jjxiDjwupW05JdupwHYDcCCsyWFtzvWRbPy9ACzHmNpHR_zJ9Z-1DbdxRcef-oPDp3CHojNZZsdvQWN2camfofM3S55Xq4zA15te2H8BjkF0Lw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immunoinformatics+Study%3A+Multi-Epitope+Based+Vaccine+Design+from+SARS-CoV-2+Spike+Glycoprotein&rft.jtitle=Vaccines+%28Basel%29&rft.au=Umitaibatin%2C+Ramadhita&rft.au=Harisna%2C+Azza+Hanif&rft.au=Jauhar%2C+Muhammad+Miftah&rft.au=Syaifie%2C+Putri+Hawa&rft.date=2023-02-01&rft.pub=MDPI+AG&rft.eissn=2076-393X&rft.volume=11&rft.issue=2&rft.spage=399&rft_id=info:doi/10.3390%2Fvaccines11020399&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2076-393X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2076-393X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2076-393X&client=summon |